 Viking Therapeutics, Inc. NASDAQ:VKTX Q2 2022 Results Conference Call July 27, 2022 4:30 PM ET Company Participants Stephanie Diaz - Manager of Investor Relations Brian Lian - President and Chief Executive Officer Greg Zante - Chief Financial Officer Conference Call Participants Steven Seedhouse - Raymond James Joseph Pantginis - H.C. Wainwright Andy Hsieh - William Blair Jay Olson - Oppenheimer Yale Jen - Laidlaw Company Operator Welcome to the Viking Therapeutics 2022 Second Quarter Financial Results Conference Call. 